Keratosis palmoplantaris cum degeneratione granulosa Q82.8

Author: Prof. Dr. med. Peter Altmeyer

Co-Autor: Alexandros Zarotis

All authors of this article

Last updated on: 20.09.2024

Dieser Artikel auf Deutsch

Synonym(s)

Epidermolytic palmoplantar keratosis; Palmoplantar keratosis epidermolytic

Definition
This section has been translated automatically.

The name and description of "keratosis palmoplantaris cum degeneratione granulosa" is only used here for historical reasons. In fact, this autosomal-dominantly inherited flat palmoplantar keratosis is referred to as keratosis palmoplantaris diffusa with mutation in KRT9 . Its clinical variability is explained by 26 mutations in the KRT9 gene (17q12-q21) that have been identified to date. KRT9 is possibly a heterodimer partner for keratin 6C (KRT6C) (Li P et al. 2023). Mutations in KRT6C are associated with a mild form of pachyonychia congenita.

Most likely, epidermolytic palmoplantar keratosis type Vörner (EPPK) and palmoplantar keratosis type Unna-Thost are distinct variants of the same disease. However, it is possible that they are one and the same disease(PPK type Unna-Thost-Vörner).

In contrast, keratosis palmoplantaris diffusa circumscripta type Norrbotten(synonyms: non-epidermolytic palmoplantar keratoderma; autosomal dominant diffuse palmoplantar keratoderma, Norrbotten type; diffuse palmoplantar keratoderma, Bothnian type) as diffuse palmoplantar keratosis with non-epidermolytic hyperkeratoses and with an underlying mutation in the aquaporin 5 gene (AQP5, 12q13.12), it occupies a genetically and phenotypically clearly defined special position.

Occurrence/Epidemiology
This section has been translated automatically.

Most frequent palmoplantar keratosis with a prevalence of 1/40,000 births.

Etiopathogenesis
This section has been translated automatically.

Defective structure of keratin due to point mutations in the gene for keratin 9 (KRT9), which is mapped on chromosome 17q12-q21. Mutations in the KRT1 gene are rarer.

Keratin 9 is expressed in the suprabasal layers of the epidermis and is specific for the skin on the palms of the hands and soles of the feet. Mutations in the keratin 9 gene lead to the breakdown of the keratin filament network and cytolysis of corneocytes.

Manifestation
This section has been translated automatically.

Mostly occurring in early childhood.

Clinical features
This section has been translated automatically.

Diffuse, non-transgenic cornification with sharp edges, red rim and ankle-cushion-like hyperkeratosis on the extensor sides of hands and feet, also watch-glass nails. Occasionally hyperhidrosis palmaris or plantaris.

Histology
This section has been translated automatically.

Acanthokeratolysis (see below degeneration, granular).

Therapy
This section has been translated automatically.

The treatment is difficult, because when the keratosis is completely detached, underlying, very touch-sensitive erythematous skin comes to the surface. The sensitivity to pain can go so far that the patient can no longer walk or touch anything. External therapy has priority, as this allows a better control of the keratolysis, i.e. only so much should be detached that good mobility is given and the occurrence of painful rhagades is prevented, but the sensitive areas remain sufficiently covered with a protective horny layer.

External therapy
This section has been translated automatically.

Softening and detachment of the horny layer is best achieved by physical and chemical methods (hot soft soap baths and corneal plane or rasp). Exteriors containing salicylic acid(e.g. 5% salicylic acid ointment) can be tried. However, they are often perceived as unpleasant. Recently, the local application of calcipotriol (e.g. psorcutane) is recommended.

Internal therapy
This section has been translated automatically.

Keratolysis cannot be adequately controlled by internal therapy. It is therefore not recommended.

Literature
This section has been translated automatically.

  1. Devos SA et al. (2003) An unusual case of palmoplantar keratoderma. J Eur Acad Dermatol Venereol 17: 68-69
  2. Küster W et al (1995) Keratosis palmoplantaris diffusa Vörner. Dermatologist 46: 705-10
  3. Li P et al. (2023) Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders. J Proteomics 287:104971.

  4. Loh TH et al. (2003) Palmar-plantar keratoderma of Unna Thost associated with atopic dermatitis: an underrecognized entity? Pediatr Dermatol 20: 195-198
  5. Lucker GPH et al. (1994) Topical calcipotriol in the treatment of epidermolytic palmoplantar keratoma of Vörner. Br J Dermatol 130: 543-5
  6. Maruyama R (1999) A case of Unna-Thost disease accompanied by Epidermophyton floccosum infection. J Dermatol 26: 63-66
  7. Mofid MZ et al. (1998) Hereditary epidermolytic palmoplantar keratoderma (Vorner type) in a family with Ehlers-Danlos syndrome. J Am Acad Dermatol 38(5 Pt 2): 825-830
  8. Reis A et al. (1994) Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 6: 174-179
  9. Thost A (1880) On hereditary ichtyosis palmaris et plantaris cornea. Dissertation (Heidelberg)
  10. Unna PG (1883) On the keratoma palmare et plantare hereditarium. Vierteljahrsschr Derm Syph (Vienna) 15: 231
  11. Vorner H (1901) Zur Kenntniss des Keratoma hereditarium palmare et plantare. Arch Derm Syph 56: 3-31
  12. Yang JM (1998) Mutations in the 1A rod domain segment of the keratin 9 gene in epidermolytic palmoplantar keratoderma. Acta Derm Venereol 78: 412-416

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 20.09.2024